Musk joins the discussion on AI risks: hope for the "good intentions" of superintelligence
A new round of confrontation is brewing in the world of high technology over the future of artificial intelligence. Elon Musk unexpectedly entered the public debate, supporting Anthropic CEO Dario Amodei in his concerns about AI safety. The billionaire's reaction came almost immediately after Amodei published a detailed post defending his position against critics accusing him of excessive pessimism.
The Core of the Conflict: Why Amodei Insists on Risks
The discussion flared up after statements by Silicon Valley executive Gavin Baker, who questioned the sincerity of Amodei's warnings. However, the head of Anthropic countered that his position is far from one-sided. In his work "Machines of Loving Grace," he deliberately balances between describing potential threats and the colossal benefits of AI adoption. According to him, short interviews and quotes taken out of context often create a false impression of gloom, whereas in reality he is calling for a balanced approach.
The key problem, according to Amodei, lies in society's deep-seated distrust of technology corporations and government institutions. This distrust, accumulated over decades, is automatically transferred to artificial intelligence as well. That is why he insists on introducing mandatory testing of advanced models instead of voluntary promises from developers. His proposal, announced in June, includes mandatory verification of AI systems before they reach the market, as well as a warning to G7 countries about the risks of regulatory fragmentation.
"The most fair criticism of AI companies, including Anthropic, is that we still haven't fulfilled the main promise: to bring benefit to the world," Amodei stated.
Musk and the Philosophical Undertone of the Dispute
Musk, commenting on this dialogue, called it "interesting" and essentially agreed with the main philosophical dilemma raised by investor Naval Ravikant: you cannot create a god and put it on a leash. Musk's response was laconic but telling: "I hope AI will be kind to us." Hidden within this restrained admission is a profound warning — if humanity loses control over superintelligence, the only hope left will be the goodwill of its own creation.
It is telling that Musk has long sympathized with Anthropic's approach, criticizing OpenAI's closedness. He sees in Amodei an alternative path for the industry's development. However, Amodei himself also enters into dispute with the libertarian view common in Silicon Valley. He notes that regulation does not always lead to a concentration of power, citing California's SB 53 bill as an example, which exempts companies with revenue below $500 million from requirements, thereby protecting small businesses.
Biotech Breakthrough and Realities
At the end of his speech, Amodei returned to his most ambitious promise: AI in biology can cure most human diseases within the next 5–10 years. This goal is not abstract for him — his father died of hepatitis C shortly before effective drugs became available. At the same time, he avoids loud slogans like "AI will cure cancer," rightly believing that real treatment protocols matter, not marketing catchphrases.
Analytical commentary: This discussion goes far beyond technological disputes and directly affects the investment climate. While regulators and giants like Anthropic and Pfizer define the contours of the future, the cryptocurrency and high-tech asset markets react sensitively to every signal. In my understanding, Musk's current rhetoric is not just support for a colleague, but a marker for institutional investors: AI safety is becoming not an option, but a mandatory condition for the sustainable growth of the entire digital economy.